Search for: "Merck and Co," Results 201 - 220 of 1,277
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Dec 2016, 1:00 pm
Eleonora Rosati discusses the VAT Directive comprising the equal treatment for both printed and electronic publications and its implications on digital exhaustion matters.Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co LimitedGuest Kat Eibhlin Vardy recaps Merck Sharp and Dohme Limited v Shionongi & Co Limited, [2016] EWHC 2989 (Pat), involving the alleged infringement of Shionogi’s European Patent, entitled… [read post]
2 Dec 2016, 3:30 am
Last week saw another Michaelmas decision from Mr Justice Arnold in the Patents Court in the form of Merck Sharpe and Dohme Limited v Shionogi & Co Limited [2016] EWHC 2989 (Pat). [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
The Merck petition is focused on pre-AIA patents. [read post]
4 Oct 2016, 1:56 pm by Tom Lamb
HBV reactivation was not reported as an adverse event in the clinical trials submitted for the DAA approvals because patients with HBV co-infection were excluded from the trials. [read post]
13 Jun 2016, 7:09 am by Editors
In a decision that will certainly be appealed, a judge ruled that in-house lawyer misconduct will result in a company losing out on quite a hefty sum: “A U.S. judge on Monday found a pattern of misconduct by Merck & Co including lying under oath and other unethical practices, freeing Gilead Sciences Inc from paying any damages for infringing Merck’s patents with its lucrative treatments for hepatitis C…The dramatic ruling comes after a… [read post]
20 May 2016, 7:06 am by Robert Kraft
Reuters reports that a Food and Drug Administration advisory panel voted 10-5 on Monday against allowing Merck & Co. to claim that Vytorin (ezetimibe and simvastatin) decreases the risk of heart attacks and strokes for coronary heart disease patients. [read post]
19 May 2016, 2:15 am by Steve Brachmann
Earlier this year, in late January, the FDA granted approval to Merck & Co. [read post]
17 May 2016, 11:25 am by Tom Lamb
About 4,400 Cases Still Pending In Federal Court MDL As Well As New Jersey And California State Courts   (Posted by Tom Lamb at DrugInjuryWatch.com)   In their corporate report Form 10-Q for the first quarter of 2016, Merck & Co., Inc. provided investors and others with their most recent update about what has been going on (or has not been, as it might seem to be the situation) with the thousands of Fosamax - femur fracture cases filed against the drug company. [read post]
28 Apr 2016, 6:30 am by Tracy Thomas
Reuters, Merck Sex Discrimination Case Could Be Collective Action A federal judge has granted preliminary approval for a lawsuit accusing Merck & Co In. of underpaying female sales representatives to go forward as a collective action. [read post]